John Stephen Healy - Jun 3, 2024 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
General Counsel and Corp Sec
Signature
/s/ Peter Slover, Attorney-in-Fact
Stock symbol
CTNM
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
4
Date filed
6/3/2024, 05:46 PM
Previous filing
Jun 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTNM Stock Option (right to buy) Award $0 +160K $0.00 160K Jun 3, 2024 Class A Common Stock 160K $15.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on June 3, 2025, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.